We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
H.B. Fuller Signs Agreements to Acquire GEM and Medifill
Read MoreHide Full Article
H.B. Fuller Company (FUL - Free Report) has inked agreements to acquire two major medical adhesive technology companies — GEM S.r.l. and Medifill Ltd.
Medifill is an Ireland-based formulator and maker of medical-grade cyanoacrylate adhesives with cutting-edge clean room and manufacturing facilities. It manufactures sophisticated technologies designed exclusively for the wound closure market. The next-generation formulas allow for fast, safe and successful wound closure. GEM is an Italy-based manufacturer and market leader in medical adhesives and unique application devices, with approval and certification for more than 80 internal indications.
The acquisition establishes a European headquarters for H.B. Fuller's Medical Adhesive Technologies ("MAT") division and broadens the company's medical adhesive solutions, further transforming its portfolio to highly profitable, high-growth industries.
These purchases add to H.B. Fuller's prior investments in the tissue adhesives market, which included the acquisition of Cyberbond in 2016, Tissue Seal in 2021 and Adhezion Biomedical in 2023, significantly broadening the company's global MAT business and geographical reach.
When the two companies are combined, net revenues and adjusted EBITDA for 2024 are estimated to be €23 million and €11.5 million, respectively. H.B. Fuller's Hygiene, Health, and Consumable ("HHC") Adhesives Global Business Unit ("GBU") will house the two businesses. The acquisitions will be closed at a pre-synergy EBITDA multiple of 15.5X and a three-year post-synergy EBITDA multiple of 9.5X for a total purchase price of €180 million.
Shares of FUL have lost 4.4% over the past year compared with 6.6% decline of its industry.
Image Source: Zacks Investment Research
FUL’s Rank & Key Picks
H.B. Fuller currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (CRS - Free Report) , DuPont de Nemours, Inc. (DD - Free Report) and CF Industries Inc. (CF - Free Report) .
Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy). CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 14.1%. The company's shares have soared 181.7% in the past year. You can see the complete list of today's Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for DD’s current-year earnings is pegged at $3.88 per share, indicating a year-over-year rise of 11.5%. DD, a Zacks Rank #2 (Buy) stock, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 12.9%. The company's shares have rallied roughly 15.8% in the past year.
The Zacks Consensus Estimate for CF’s current-year earnings is pegged at $6.32 per share. CF, a Zacks Rank #1 stock, beat the consensus estimate in two of the last four quarters while missed twice, with the average earnings surprise being 10.3%. CF has rallied around 20.3% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
H.B. Fuller Signs Agreements to Acquire GEM and Medifill
H.B. Fuller Company (FUL - Free Report) has inked agreements to acquire two major medical adhesive technology companies — GEM S.r.l. and Medifill Ltd.
Medifill is an Ireland-based formulator and maker of medical-grade cyanoacrylate adhesives with cutting-edge clean room and manufacturing facilities. It manufactures sophisticated technologies designed exclusively for the wound closure market. The next-generation formulas allow for fast, safe and successful wound closure. GEM is an Italy-based manufacturer and market leader in medical adhesives and unique application devices, with approval and certification for more than 80 internal indications.
The acquisition establishes a European headquarters for H.B. Fuller's Medical Adhesive Technologies ("MAT") division and broadens the company's medical adhesive solutions, further transforming its portfolio to highly profitable, high-growth industries.
These purchases add to H.B. Fuller's prior investments in the tissue adhesives market, which included the acquisition of Cyberbond in 2016, Tissue Seal in 2021 and Adhezion Biomedical in 2023, significantly broadening the company's global MAT business and geographical reach.
When the two companies are combined, net revenues and adjusted EBITDA for 2024 are estimated to be €23 million and €11.5 million, respectively. H.B. Fuller's Hygiene, Health, and Consumable ("HHC") Adhesives Global Business Unit ("GBU") will house the two businesses. The acquisitions will be closed at a pre-synergy EBITDA multiple of 15.5X and a three-year post-synergy EBITDA multiple of 9.5X for a total purchase price of €180 million.
Shares of FUL have lost 4.4% over the past year compared with 6.6% decline of its industry.
Image Source: Zacks Investment Research
FUL’s Rank & Key Picks
H.B. Fuller currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (CRS - Free Report) , DuPont de Nemours, Inc. (DD - Free Report) and CF Industries Inc. (CF - Free Report) .
Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy). CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 14.1%. The company's shares have soared 181.7% in the past year. You can see the complete list of today's Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for DD’s current-year earnings is pegged at $3.88 per share, indicating a year-over-year rise of 11.5%. DD, a Zacks Rank #2 (Buy) stock, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 12.9%. The company's shares have rallied roughly 15.8% in the past year.
The Zacks Consensus Estimate for CF’s current-year earnings is pegged at $6.32 per share. CF, a Zacks Rank #1 stock, beat the consensus estimate in two of the last four quarters while missed twice, with the average earnings surprise being 10.3%. CF has rallied around 20.3% in the past year.